Page 51 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Post Graduate Course - Metabolic Liver Disease (Cont.) Hall D

NAFLD and Interactions with Insulin Resistance

14:00 - 14:15 Q&A (QUESTIONS) case presentation
Pierre-Emmanuel Rautou, France

14:15 - 14:35 Excessive body weight and risk of NASH: are all obese patients SCIENTIFIC PROGRAMME
equal?
Amalia Gastaldelli, Italy

14:35 - 14:55 Insulin resistance: should we measure it and does it promote
liver disease progression?
Elisabetta Bugianesi, Italy

14:55 - 15:15 Dysmetabolic hyperferritinemia
Yves Deugnier, France

15:15 - 15:35 Bariatric surgery: a cure for NASH?
Carel Leroux, The United Kingdom

15:35 - 15:40 Q&A (ANSWERS)

15:40 - 16:00 Coffee Break

Extrahepatic Complications of Liver Fat

16:00 - 16:15 Q&A (QUESTIONS) case presentation
Fabio Nascimbeni, Italy

16:15 - 16:35 Why does liver fat contribute to cardio-metabolic outcomes?
Hannele Yki-Jarvinen, Finland

16:35 - 16:55 NAFLD, pre-atherogenic lesions and cardiovascular events
Sven Francque, Belgium

16:55 - 17:15 Does steatosis place patients at risk for diabetes development
and progression?
Naveed Sattar, The United Kingdom

17:15 - 17:35 Current and future insulin sensitizers in the treatment of
NASH?
Vlad Ratziu, France

17:35 - 17:40 Q&A (ANSWERS)

Vienna, Austria • April 22–26, 2015 51